Adaptive dose painting for prostate cancer

Emil Fredén1, David Tilly2,3, Anders Ahnesjö2

  • 1Department of Oncology, Södersjukhuset, Stockholm, Sweden.

Frontiers in Oncology
|October 14, 2022
PubMed
Summary

Adaptive radiation therapy (ART) improves dose painting (DP) for prostate cancer, maintaining high tumor control probability (TCP) and avoiding misses seen in conventional workflows.

Related Concept Videos